Placebo Effect: Clinical Trials

3 trials of Placebo Effect, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting, 1 terminated. 3 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Completed 1, Recruiting 1, Terminated 1
Phase 22Recruiting 1, Terminated 1

Follow Placebo Effect: new trials by email Literature Review of Placebo Effect trials Research Report on Placebo Effect

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Treatment for a Form of Age-Related Central Auditory Processing Disorder Consisting of Clemastine Fumarate Plus Engineered Sound
Clemastine Fumarate Combined With Engineered Sound, Clemastine Fumarate Combined With Pink Noise, Placebo Drug With Engineered Sound - Central Auditory Processing Disorder, Hearing Impaired (Partially)
Phase 1 / Phase 2RecruitingUniversity of Colorado, Denver3442025-03-312026-04-30
Vitamin C, Steroids, and Thiamine, and Cerebral Autoregulation and Functional Outcome in Septic Shock
Stress-dose Hydrocortisone plus Vitamin C, isotonic sodium chloride solution placebo plus isotonic sodium chloride solution placebo - Septic Shock
Phase 1 / Phase 2TerminatedUniversity of Athens262018-09-062024-12-19
Assessment of the Safety, Tolerability and Pharmacodynamics After Administration of One Dose of AZD8601 to Male Patients With Type II Diabetes Mellitus (T2DM)
AZD8601+Placebo (SAD), AZD8601+Placebo, Placebo+Placebo - Male Subjects With Type II Diabetes (T2DM)
Phase 1CompletedAstraZeneca442016-12-162020-01-18

Conditions studied

Auditory Diseases, Central (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Hearing Disorders (1)  ·  Hearing Loss (1)  ·  Hearing Loss, Hidden (1)  ·  Hearing Loss, Noise-Induced (1)  ·  Hearing Loss, Sensorineural (1)  ·  Language Development Disorders (1)  ·  Presbycusis (1)  ·  Shock, Septic (1)

Sponsors

AstraZeneca (1)  ·  University of Athens (1)  ·  University of Colorado, Denver (1)

Countries

Germany (1)  ·  Greece (1)  ·  United States (1)

Top investigators

Achim Klug, PhD (1)  ·  Anastasia Kotanidou, MD, PhD (1)  ·  Rainard Fuhr, Dr. med. (1)  ·  Samuel A Budoff, PhD, MS (1)  ·  Spyros D Mentzelopoulos, MD, PhD (1)  ·  Spyros G Zakynthinos, MD. PhD (1)  ·  Stylianos Orfanos, MD, PhD (1)

NIH funding

2016 (1)